Spirochete Infections: Neurosyphilis
Definition
Infection of brain, meninges, or spinal cord by Treponema pallidum.
Required: (a) syndrome consistent with neurosyphilis (meningitis, meningoencephalitis, meningomyelitis, cerebral infarcts, dementia paralytica, tabes dorsalis, congenital neurosyphilis, asymptomatic neurosyphilis); (b) abnormal blood titer of treponemal antibody test; (c) positive nontreponemal antibody test in CSF.
Epidemiology
Incidence declined following introduction of penicillin, then increased with AIDS epidemic.
10% of untreated patients with early syphilis develop neurosyphilis. Of HIV-positive patients, 15% have concomitant serologic evidence of syphilis; 1% have neurosyphilis.
Pathology
Early neurosyphilis: mononuclear cell infiltration of meninges, extending to cranial nerves (causing axonal degeneration) and endothelial proliferation with vessel occlusion (focal ischemic necrosis in brain and spinal cord).
Dementia paralytica: inflammation around small cortical vessels provokes loss of cortical neurons and glial proliferation. Spirochetes in cortex.
Tabes dorsalis: degeneration of posterior roots and posterior fiber columns of spinal cord.
Investigations
Serology
Nontreponemal antibody tests: VDRL, RPR. Both performed on serum; VDRL suitable for testing CSF.
Fluorescent treponemal antibody (FTA-ABS) titer: highly sensitive and specific. Performed as confirmatory test if RPR or VDRL is positive.
CSF
CSF pleocytosis best measure of disease activity. CSF protein usually increased. Glucose low or normal.
